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Abstract
The possible connection between chronic oral inflammatory processes, such as apical periodontitis and perio-
dontal disease (PD), and systemic health is one of the most interesting aspects faced by the medical and dental 
scientific community. Chronic apical periodontitis shares important characteristics with PD: 1) both are chronic 
infections of the oral cavity, 2) the Gram-negative anaerobic microbiota found in both diseases is comparable, and 
3) in both infectious processes increased local levels of inflammatory mediators may have an impact on systemic 
levels. One of the systemic disorders linked to PD is diabetes mellitus (DM); is therefore plausible to assume that 
chronic apical periodontitis and endodontic treatment are also associated with DM. The status of knowledge regar-
ding the relationship between DM and endodontics is reviewed. Upon review, we conclude that there are data in 
the literature that associate DM with a higher prevalence of periapical lesions, greater size of the osteolityc lesions, 
greater likelihood of asymptomatic infections and worse prognosis for root filled teeth. The results of some studies 
suggest that periapical disease may contribute to diabetic metabolic dyscontrol.
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Introduction
Apical periodontitis (AP) is an acute or chronic infla-
mmatory lesion around the apex of a tooth caused by 
bacterial infection of the pulp canal system. Periradi-
cular lesions consecutive to AP result from a periapi-
cal inflammatory response provoked by polymicrobial 
irritants from root canals. AP is a remarkably prevalent 
problem (1). In Europe, the prevalence of AP rises 61%, 
increasing with patients age (2). When apical periodon-
titis has occurred treatment is aimed at restoring the pe-
riradicular tissues to health: this is usually carried out 
by root canal treatment, occasionally in combination 
with surgical endodontics. In Europe, the prevalence of 
endodontic treatment is estimated around 41% (2).
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Although the periradicular infectious process produces 
a variety of local tissue responses with the likely pur-
pose to confine and limit the spreading of the infectious 
elements, AP may not exclusively be a local phenome-
non.  In its non-balanced acute stage, spreading of the 
infection and the inflammatory process to nearby tissue 
compartments is possible and may bring about severe, 
but fortunately rare, fatal inflammatory conditions. Mo-
reover, considering the increasing awareness of a po-
tential relationship between persistent, inflammatory 
disorders of the oral cavity and disease conditions in 
other organs of the body, acute and chronic manifesta-
tions of AP may also be implicated (3).
The possible connection between chronic oral inflam-
matory processes of infectious origin, i.e. chronic apical 
periodontitis and periodontal disease (PD), and syste-
mic health is one of the most interesting aspects faced 
by the medical and dental scientific community. In the 
two last decades several epidemiological studies have 
investigated the association between systemic health 
and PD. Thus, PD has been associated to diabetes mel-
litus (DM) (4,5), coronary heart disease (CHD) (6) and 
acute myocardial infarction (AMI) (7), preterm-low 
birth weight (8), respiratory diseases (9) and osteopo-
rosis in post-menopause women (10). The evidence of 
the association between PD and systemic diseases has 
increased the attention at the diagnosis and treatment 
of PD, improving, consequently, the patient’s oral and 
systemic health (11). 
Although some differences are evident between chronic 
periodontal and periapical inflammatory processes, both 
show three important resemblances: 1) both are chronic 
infections of the oral cavity, 2) both are polymicrobial 
infections sharing a common microbiota with predomi-
nance of Gram-negative anaerobic bacteria (12), and 3) 
elevated cytokine levels may be released systemically 
from acute and chronic manifestations of both disease 
processes (e.g., increased concentrations of inflamma-
tory mediators have been detected both in the gingival 
crevicular fluid of subjects with periodontal disease and in 
the periapical tissues of endodontically involved teeth) (13). 
Likewise, it can be assumed that AP is linked with the 
same systemic disorders associated to PD (3). Conse-
quently, numerous investigations have been conducted 
to study the relationship between AP and coronary 
heart disease (13,14), hypertension (15-17), and smoking 
(18). Moreover, several studies have analyzed the pos-
sible association between AP and DM, a clinically and 
genetically heterogeneous group of disorders affecting 
the metabolism of carbohydrates, lipids and proteins, in 
which hyperglycaemia is a main feature. In this paper, 
the current status of knowledge regarding the relations-
hip between AP and DM is reviewed.
Diabetes Mellitus
Diabetes mellitus (DM) is a group of complex multisys-
tem metabolic disorders due to a deficiency in insulin 
secretion caused by pancreatic β-cell dysfunction and/or 
insulin resistance in liver and muscle. Diabetes affects 
more than 9% of the adult population and has a drama-
tic impact on the health care system through high mor-
bidity and mortality among affected individuals (19).
Type 1 diabetes results from cellular-mediated autoim-
mune destruction of pancreatic β-cells, which usually 
leads to total loss of insulin secretion; in contrast, type 
2 diabetes is caused by resistance to insulin combined 
with a failure to produce enough additional insulin to 
compensate for the resistance. Type 2 diabetes is com-
monly linked to obesity, which contributes to insulin 
resistance through elevation of circulating levels of 
free fatty acids derived from the adipocytes; these free 
fatty acids inhibit glucose uptake, glycogen synthesis 
and glycolysis. In many obese individuals, insulin resis-
tance is compensated by increased insulin production. 
However, in one-third of obese individuals, β-cell mass 
is reduced by a marked increase in β-cell apoptosis, 
which results in inadequate production of insulin (20).
Association between diabetes mellitus, pe-
riapical status and the outcome of root canal 
treatment
DM affects many functions of the immune system and is 
associated with delayed healing and compromised immu-
ne responses (21). DM-induced changes in immune cell 
function produce an inflammatory immune cell pheno-
type (up-regulation of pro-inflammatory cytokines from 
monocytes / polymorphonuclear leukocytes and down-
regulation of growth factors from macrophages). This 
predisposes to chronic inflammation, progressive tissue 
breakdown, and diminished tissue repair capacity (22). 
Evidence has consistently indicated that diabetes is a risk 
factor for increased severity of gingivitis and periodonti-
tis (23).  So, it is plausible to hypothesize that DM predis-
poses to oral infection and could also act as a risk factor 
for AP, increasing the rate of root canal treatment failure. 
Several studies have tried to answer this hypothesis.
Animal studies
The relationship between endodontic infections and DM 
has been investigated in animal models. Kohsaka et al. 
(24) studied histologically and histometrically the chan-
ges in pulpal and periapical tissues after pulpal exposure 
in streptozotocin-induced diabetic rats. In experimental 
rats, inflammation in the apical periodontal ligament and 
root resorption and alveolar bone resorption were more 
severe than that in control rats. Fouad et al. (25) indu-
ced periapical lesions in first molars of female nonobese 
diabetic (NOD) mice and measured periapical lesion size 
histomorphometrically, finding a more severe response 
in diabetic mice compared with controls. Iwama et al. 
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(26) evaluated the effects of type 2 diabetes on the de-
velopment of periradicular lesions after exposure of the 
pulp in the left mandibular first molar through the occlu-
sal surface in Goto-Kakizaki (GK) rats with spontaneous 
non-insulin-dependent diabetes mellitus and Wistar rats 
(controls). Four weeks after pulp exposure, histologic 
analysis showed that alveolar bone resorption was most 
severe and the periradicular lesions were largest in diabe-
tic rats given a sucrose solution, suggesting that the me-
tabolic conditions produced by type 2 diabetes enhance 
the development of periradicular lesions in rats. Recently, 
Garber et al. (27) have studied the effect of hyperglycae-
mia on pulpal healing in exposed rat pulps capped with 
mineral trioxide aggregate. Two groups of 11 rats recei-
ved injections of saline (control group) or streptozotocin 
to induce hyperglycaemia (DM group). The pulps of the 
maxillary first molars of all rats were exposed and ca-
pped. Intact teeth and teeth with exposed pulps without 
restorations served as positive and negative controls, res-
pectively. Dentin bridge formation was inhibited in dia-
betic rats (p = 0.029) along with more inflammation in 
these pulps (p = 0.005). There was an inverse association 
between dentin bridge formation and inflammatory cell 
infiltration (p = 0.001). Based on these results, the authors 
conclude that it appears that hyperglycemia adversely 
affects pulpal healing in rats.
Human studies
The literature on the pathogenesis, progression, and 
healing of AP in diabetic patients is scarce. Bender et al. 
(28) reported that, in cases of poorly controlled DM, pe-
riapical radiolucencies tend to develop during treatment 
but, if DM is under therapeutic control, periapical le-
sions heal as readily as in non-diabetics. Cheraskin & 
Ringsdorf (29) monitored radiographically the healing 
of periradicular lesions following root canal treatment 
in twelve patients with low plasma glucose and thirteen 
patients with high glucose. After thirty weeks, the peri-
radicular radiolucencies in the low glucose groups were 
reduced by an average of 74 percent compared with a 
reduction of only 48 percent for the high glucose group. 
Bender & Bender (30) found a high rate of asymptomatic 
tooth infections in diabetics exhibiting poor glycaemia 
levels of an unclear cause. Falk et al. (31) conducted a 
clinical and radiographic investigation showing a grea-
ter prevalence of periapical lesions in type 1 diabetics. 
They observed that women with long diabetes duration 
exhibited more root-filled teeth with periapical lesions 
than women with short diabetes duration and women 
without diabetes. Long duration diabetics exhibited tee-
th with more periapical lesions than the other groups. 
Ueta et al. (32) studied the prevalence of DM in odonto-
genic infections reporting that patients with DM had a 
disproportionately high percentage of clinically severe 
pulpal or periodontal infections (24% of all cases), but 
had a much lower percentage of moderate infections 
(2.3%), concluding that DM was a predisposing condi-
tion for endodontic infections. Fouad et al. (25) descri-
bed the association of Porphyromonas gingivalis and 
Porphyromonas endodontalis isolated in samples from 
root canals with necrotic pulp and a history of diabetes 
mellitus (OR > 2), but the sample was too small to esta-
blish any definitive association.
Fouad & Burleson (33) investigated endodontic diagnostic 
and treatment outcome data in patients with and without 
diabetes. A multivariate analysis showed that patients with 
diabetes have increased periodontal disease in root-filled 
teeth and have a reduced likelihood of success of root canal 
treatment in cases with preoperative periradicular lesions. 
Britto et al. (34) investigate the prevalence of radiographic 
periradicular radiolucencies in root-filled teeth and un-
treated teeth in patients with and without diabetes. Results 
showed that men with type 2 diabetes who had root canal 
treatments were more likely to have residual lesions. In a 
retrospective cohort study, Segura-Egea et al. (35) deter-
mined radiographycally the prevalence of AP in patients 
with and without type 2 diabetes mellitus. Results showed 
that apical periodontitis in at least one tooth was found in 
81.3% of diabetic patients and in 58% of control subjects (p 
= 0.036; OR = 3.2, 95% C.I. = 1.1 - 9.4). Amongst diabetic 
patients 7% of the teeth had AP, whereas in the control 
subjects 4% of teeth were affected (p = 0.007; OR = 1.8, 
95% C.I. = 1.2 - 2.8). Mindiola et al. (15) carried out an 
epidemiological study of a regional population of Native 
Americans identifying factors affecting the retention of 
root-filled teeth and to determine frequencies of endodon-
tic care. The results suggested that diabetes contributes to 
decreased retention of root-filled teeth. Doyle et al. (36), 
in a retrospective study, evaluated whether diabetes was 
associated with the outcome of patients undergoing non-
surgical root canal treatment, finding a borderline signifi-
cantly association (p = 0.063). Wang et al. (17) analyzed the 
long-term prognosis of teeth receiving non-surgical root 
canal treatment (NSRCT) in patients with DM to elucida-
te the impact of DM on the risk of tooth extraction after 
NSRCT. Results showed that DM was a significant risk 
factor for tooth extraction after NSRCT (p < 0001; OR = 
1.8). A recent prospective epidemiologic study, using self-
reported history of root canal therapy, concluded that dia-
betes was more prevalent among patients with CHD with 
24 or fewer teeth reporting never having had endodontic 
treatment (14).
Since diabetes is the third most prevalent condition in me-
dically compromised patients seeking dental treatment 
(37), dentists should be aware of the possible relationship 
between endodontic infections and diabetes and take it 
into account in the attention to diabetic patients.
Possible effect of periapical infection on diabe-
tes mellitus
It has been stated that PD can have a significant im-
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Fig. 1. Interaction between endodontic infection and diabetes mellitus. LPS: lipopolysaccharide; NF-kβ: nuclear factor kappaβ; CAP: chronic 
apical periodontitis. 
pact on the metabolic state in diabetes. The presence of 
periodontitis increases the risk of worsening of glyce-
mic control over time (11). It has been proposed that PD 
could initiate or propagate insulin resistance in a simi-
lar manner to that of obesity, by enhancing activation of 
the overall systemic immune response initiated by cyto-
kines (5). Several biologically plausible mechanisms 
could be proposed to explain the interactions between 
diabetes and PD. Type 2 diabetes is a manifestation of 
the host’s inflammatory response, because an ongoing 
cytokine-induced acute-phase response (a low-grade 
inflammation that occurs through activation of the in-
nate immune system) is closely involved in the pathoge-
nesis of this disease (20). Likewise, the mechanisms of 
the host-mediated response in PD involve activation of 
the broad axis of innate immunity, specifically by up-
regulation of proinflammatory cytokines from mono-
cytes and polymorphonuclear leukocytes. Thus, chro-
nic gram-negative periodontal infections may induce or 
perpetuate an elevated chronic systemic inflammatory 
status, contributing to increased insulin resistance and 
poor glycemic control (11).
As it has been exposed previously, there are important 
similitudes between PD and AP. So, it could be hypo-
thesized that chronic periapical inflammatory processes 
can also contribute to the pathogenesis of DM, being 
a risk factor for worsening glycaemia control among 
diabetic patients. Some investigations have analyzed 
this topic. Bender et al. (28) reported that inflammatory 
periapical reactions are greater in diabetic states, and 
the increased local inflammation causes an intensifica-
tion of diabetes with a rise in blood glucose, placing 
the patient in an uncontrolled diabetic state. This often 
requires an increase in insulin dosage or therapeutic 
adjustment. Removal of the inflammatory state usually 
creates a need for a lesser amount of insulin for diabetic 
control. Thus, it becomes axiomatic to remove all in-
fections including those of the dental pulps. Schulze et 
al. (38) described the effects of an acute focal dental in-
flammation and subsequent root canal treatment on the 
required insulin dosage of a 70-year-old man who had 
moderately controlled diabetes. This case report shows 
a highly relevant correlation between insulin resistance 
and a local dental inflammation of endodontic origin. 
The mechanisms of the effect of chronic periapical in-
fections on diabetic patients must be similar to that exis-
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ting between PD and DM (Fig. 1) (20). Chronic inflam-
mation through the action of inflammatory mediators 
is mainly associated with the development of insulin 
resistance, which is influenced by genetically modified 
environmental factors, including decreased physical ac-
tivity, poor nutrition, obesity and infection (39). Chro-
nic apical periodontitis involves activation of the broad 
axis of innate immunity. The lipopolysaccharide (LPS) 
from anaerobic gram-negative bacteria causing apical 
periodontitis activates intracellular pathways (nuclear 
factor kappa B, NF-kβ) on macrophages and neutro-
phils, upregulating pro-inflammatory cytokines such as 
IL-1β, IL-6, IL-8, tumour necrosis factor alpha (TNF-α) 
and prostaglandin E2 (PGE2). These locally produced 
cytokines move into the systemic circulation (36), whe-
re they interact with the free fatty acids and advanced 
products of glycosylation (AGEs), characteristic of type 
2 DM. The activation of these inflammatory pathways 
in immune cells (monocytes or macrophages), endothe-
lium cells, adipocytes, hepatocytes and muscle cells 
could promote an increase in the overall insulin resis-
tance, altering the metabolic control in patients with 
both type 2 diabetes and chronic apical periodontitis.
The results of studies conducted so far are not conclusi-
ve, but suggest an association between DM an AP. The-
re is evidence from the literature associating DM with 
higher prevalence of AP, greater size of the periapical 
osteolytic lesions, greater likelihood of asymptomatic 
periapical infections, and delay / arrest of periapical 
repair. The prognosis for root filled teeth is worse in 
diabetics, showing a higher rate of root canal treatment 
failure with increased prevalence of persistent chronic 
apical periodontitis. The results of some studies suggest 
that chronic periapical disease may contribute to diabe-
tic metabolic dyscontrol. Prospective epidemiological 
studies are needed to deepen the relationship between 
DM and periapical inflammation.
References
1. Figdor D. Apical periodontitis: a very prevalent problem. Oral 
Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:651-2.
2. Jiménez-Pinzón A, Segura-Egea JJ, Poyato-Ferrera M, Velasco-
Ortega E, Ríos-Santos JV. Prevalence of apical periodontitis and fre-
quency of root-filled teeth in an adult Spanish population. Int Endod 
J. 2004;37:167-73.
3. Joe Editorial Board. Relationship between systemic diseases and 
endodontics: An online study guide. J Endod. 2008;34 Suppl:e195-
200.
4. Soskolne WA, Klinger A. The relationship between periodontal 
diseases and diabetes: an overview. Ann Periodontol. 2001;6:91-8.
5. Katz J. Elevated blood glucose levels in patients with severe peri-
odontal disease. J Clin Periodontol. 2001;28:710-2.
6. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodon-
tal disease and cardiovascular disease. J Periodontol. 1996;67:1123-
37.
7. Grau AJ, Becher H, Ziegler CM, Lichy C, Buggle F, Kaiser C, et 
al. Periodontal disease as a risk factor for ischemic stroke. Stroke. 
2004;35:496-501.
8. Marín C, Segura-Egea JJ, Martinez-Sahuquillo A, Bullon P. Cor-
relation between infant birth weight and mother’s periodontal status. 
J Clin Periodontol. 2005;32:299-304.
9. Scannapieco FA, Bush RB, Paju S. Associations between peri-
odontal disease and risk for nosocomial bacterial pneumonia and 
chronic obstructive pulmonary disease. A systematic review. Ann 
Periodontol. 2003;8:54-69.
10. Bullón P, Goberna B, Guerrero JM, Segura JJ, Perez-Cano R, 
Martinez-Sahuquillo A. Serum, saliva, and gingival crevicular fluid 
osteocalcin: their relation to periodontal status and bone mineral 
density in postmenopausal women. J Periodontol. 2005;76:513-9.
11. Montoya-Carralero JM, Saura-Pérez M, Canteras-Jordana M, 
Morata-Murcia IM. Reduction of HbA1c levels following nonsurgi-
cal treatment of periodontal disease in type 2 diabetics. Med Oral 
Patol Oral Cir Bucal. 2010;15:e808-12.
12. Sundqvist G. Ecology of the root canal flora. J Endod. 1992;18:427-
30.
13. Caplan DJ, Chasen JB, Krall EA, Cai J, Kang S, Garcia RI, et al. 
Lesions of endodontic origin and risk of coronary heart disease. J 
Dent Res. 2006;85:996-1000.
14. Caplan DJ, Pankow JS, Cai J, Offenbacher S, Beck JD. The re-
lationship between self-reported history of endodontic therapy and 
coronary heart disease in the Atherosclerosis Risk in Communities 
Study. J Am Dent Assoc. 2009;140:1004-12.
15. Mindiola MJ, Mickel AK, Sami C, Jones JJ, Lalumandier JA, 
Nelson SS. Endodontic treatment in an American Indian population: 
A 10-year retrospective study. J Endod. 2006;32:828–32.
16. Segura-Egea JJ, Jimenez-Moreno E, Calvo-Monroy C, Ríos-San-
tos JV, Velasco-Ortega E, Sánchez-Domínguez B, et al. Hyperten-
sion and dental periapical condition. J Endod. 2010;36:1800-4.
17. Wang CH, Chueh LH, Chen SC, Feng YC, Hsiao CK, Chiang 
CP. Impact of diabetes mellitus, hypertension, and coronary artery 
disease on tooth extraction after nonsurgical endodontic treatment. 
J Endod. 2011;37:1-5.
18. Segura-Egea JJ, Jiménez-Pinzón A, Ríos-Santos JV, Velasco-Or-
tega E, Cisneros-Cabello R, Poyato-Ferrera MM. High prevalence of 
apical periodontitis amongst smokers in a sample of Spanish adults. 
Int Endod J. 2008;41:310-6.
19. Manfredi M, McCullough MJ, Vescovi P, Al-Kaarawi ZM, Porter 
SR. Update on diabetes mellitus and related oral diseases. Oral Dis-
eases. 2004;10:187-200.
20. Santos Tunes R, Foss-Freitas MC, Nogueira-Filho Gda R. Impact 
of periodontitis on the diabetes-related inflammatory status. J Can 
Dent Assoc. 2010;76:a35.
21. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allan-
nic H, Genetet B. Impaired leukocyte functions in diabetic patients. 
Diabet Med. 1997;14:29-34.
22. Iacopino AM. Periodontitis and diabetes interrelationships: role 
of inflammation. Ann Periodontol 2001;6:125-37.
23. Salvi GE, Carollo-Bittel B, Lang NP. Effects of diabetes mellitus 
on periodontal and peri-implant conditions: update on associations 
and risks. J Clin Periodontol. 2008;35:398-409.
24. Kohsaka T, Kumazawa M, Yamasaki M, Nakamura H. Periapi-
cal lesions in rats with streptozotocin-induced diabetes. J Endod. 
1996;22:418-21.
25. Fouad A, Barry J, Russo J, Radolf J, Zhu Q. Periapical lesion 
progression with controlled microbial inoculation in a type I diabetic 
mouse model. J Endod. 2002;28:8-16.
26. Iwama A, Nishigaki N, Nakamura K, Imaizumi I, Shibata N, 
Yamasaki M, et al. The effect of high sugar intake on the develop-
ment of periradicular lesions in rats with type 2 diabetes. J Dent Res. 
2003;82:322-25.
27. Garber SE, Shabahang S, Escher AP, Torabinejad M. The effect 
of hyperglycemia on pulpal healing in rats. J Endod. 2009;35:60-2.
28. Bender IB, Seltzer S, Freedland J. The relationship of systemic 
diseases to endodontic failures and treatment procedures. Oral Surg 
Oral Med Oral Pathol. 1963;16:1102-15.
29. Cheraskin E, Ringsdorf WM Jr. The biology of the endodontic 
patient. 3. Variability in periapical healing and blood glucose. J Oral 
Med. 1968;23:87-90.
Med Oral Patol Oral Cir Bucal. 2012 Mar 1;17 (2):e356-61.                                                                                                                                                               Diabetes mellitus and endodontics
e361
30. Bender IB, Bender AB. Diabetes mellitus and the dental pulp. J 
Endod. 2003;29:383–9.
31. Falk H, Hugoson A, Thorstensson H. Number of teeth, prevalence 
of caries and periapical lesions in insulin-dependent diabetics. Scand 
J Dent Res. 1989;97:198-206.
32. Ueta E, Osaki T, Yoneda K, Yamamoto T. Prevalence of diabetes 
mellitus in odontogenic infections and oral candidiasis: an analysis 
of neutrophil suppression. J Oral Pathol Med. 1993;22:168-74.
33. Fouad AF, Burleson J. The effect of diabetes mellitus on endo-
dontic treatment outcome: data from an electronic patient record. J 
Am Dent Assoc. 2003;134:43-51.
34. Britto LR, Katz J, Guelmann M, Heft M. Periradicular radio-
graphic assessment in diabetic and control individuals. Oral Surg 
Oral Med Oral Pathol Oral Radiol Endod. 2003;96:449–52.
35. Segura-Egea JJ, Jiménez-Pinzón A, Ríos-Santos JV, Velasco-
Ortega E, Cisneros-Cabello R, Poyato-Ferrera M. High prevalence 
of apical periodontitis amongst type 2 diabetic patients. Int Endod 
J. 2005;38:564-9.
36. Doyle SL, Hodges JS, Pesun IJ, Baisden MK, Bowles WR. Fac-
tors affecting outcomes for single-tooth implants and endodontic 
restorations. J Endod. 2007;33:399-402.
37. Dhanuthai K, Sappayatosok K, Bijaphala P, Kulvitit S, Sereerat T. 
Prevalence of medically compromised conditions in dental patients. 
Med Oral Patol Oral Cir Bucal. 2009;14:E287-91.
38. Schulze A, Schönauer M, Busse M. Sudden improvement of in-
sulin sensitivity related to an endodontic treatment. J Periodontol. 
2007;78:2380-4.
39. Pickup JC. Inflammation and activated innate immunity in the 
pathogenesis of type 2 diabetes. Diabetes Care. 2004;27:813-23.
